Company / Tangible Book Value per Share
ADMA Biologics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.00
FY2025
5-year range
$0.43 / $2.00
FY2021-FY2025
Trend
+31.0%
vs FY2024
Sector context
#143 of 209
Health Care
What the data says
At $2.00, ADMA Biologics, Inc.'s tangible book value per share ranks #143 of 209 in the Health Care sector. Tangible Book Value per Share has increased for 3 consecutive years, from $0.43 in FY2022 to $2.00 in FY2025.
Based on SEC 10-K filings.
2.00 in FY2025 with a 5-year CAGR of +7.0%.
Improved from $0.59 to $2.00 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +66.6%
- 5-Year CAGR
- +7.0%
- 10-Year CAGR
- -
Sector benchmark
#143 of 209 in Health CareTop 68% of 209This company $2.00 Sector average $119.74
▼
-98.3% below sector average
Key checks
Key Insights
- ADMA Biologics, Inc.'s tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 31.0% year-over-year.
- Ranks #143 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.00 | +31.0% |
| FY2024 | $1.53 | +157.4% |
| FY2023 | $0.59 | +37.2% |
| FY2022 | $0.43 | -67.0% |
| FY2021 | $1.31 | -8.1% |
| FY2020 | $1.43 | +192.1% |
| FY2019 | $0.49 | +10.6% |
| FY2018 | $0.44 | +227.9% |
| FY2017 | -$0.35 | +16.9% |
| FY2016 | -$0.42 | -164.3% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026